Back
Axsome Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
AXSM
Axsome Therapeutics
Last Price:
$105.15
Seasonality Move:
11.24%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.04 | Buy |
| 20-day SMA: | 107.56 | Sell |
| 50-day SMA: | 108.6 | Sell |
| 200-day SMA: | 100.76 | Buy |
| 8-day EMA: | 105.1 | Buy |
| 20-day EMA: | 106.41 | Sell |
| 50-day EMA: | 108.37 | Sell |
| 200-day EMA: | 101.54 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 45.61 | Sell |
| Chaikin Money Flow: | 359502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.64 - 111.3) | Sell |
| Bollinger Bands (100): | (97.44 - 123.32) | Sell |
Axsome Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 105.16 while AXSM 8-day simple moving average is 105.04, which is a Buy signal.
-
The stock price of AXSM is 105.16 while Axsome Therapeutics 20-day SMA is 107.56, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 108.60 while AXSM share price is 105.16, making it a Sell technically.
-
AXSM stock price is 105.16 and Axsome Therapeutics 200-day simple moving average is 100.76, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
45
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $105.16. The Score for AXSM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.2B
Price in USD:
105.16
Share Volume:
485.8K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
45
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 105.16 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 105.16 while AXSM 8-day exponential moving average is 105.10, which is a Buy signal.
-
The stock price of AXSM is 105.16 while Axsome Therapeutics 20-day EMA is 106.41, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 108.37 while AXSM share price is 105.16, making it a Sell technically.
-
AXSM stock price is 105.16 and Axsome Therapeutics 200-day simple moving average is 101.54, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.99 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -1.3, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 45.61, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (104.64 - 111.3), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (97.44 - 123.32), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.